{
    "code": "02024603",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024603",
    "time": "2023-07-20 21:54:59",
    "許可證字號": "衛署藥輸字第024603號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/26",
    "發證\/登錄日期": "96\/01\/26",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202460303",
    "中文品名": "易解鐵可溶錠125毫克",
    "英文品名": "Exjade 125mg dispersible tablets",
    "適應症": "治療因輸血而導致慢性鐵質沈著症(輸血性血鐵質沉積)的成年人及2歲以上兒童患者。\r\n治療10 歲以上非輸血依賴型(non-transfusion dependent)海洋性貧血患者之慢性鐵質沉著症",
    "劑型": "120可溶錠",
    "包裝": "12-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DEFERASIROX",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "SANDOZ S.R.L.",
            "製造廠廠址": "STR. LIVEZENI NR. 7A, 540472, TARGU MURES, JUD. MURES, ROMANIA",
            "製造廠公司地址": "",
            "製造廠國別": "ROMANIA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASLE SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099100",
            "成分名稱": "DEFERASIROX",
            "含量描述": "",
            "含量": "125.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "024603_Exjade 125mg dispersible tablets-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024603&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Exjade_46309623_TW_LFT_P03-111-12-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024603&Seq=037&Type=9"
        },
        {
            "title": "17031_Exjade 125 mg_TWI-060220_C-109-02-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024603&Seq=036&Type=9"
        },
        {
            "title": "Exjade 125mg_FB-109-05-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024603&Seq=009&Type=8"
        },
        {
            "title": "易解鐵可溶錠 Exjade 125mg_FB-105-06-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024603&Seq=008&Type=8"
        }
    ]
}